ZA200609895B - Methods for treating a mammal before, during and after cardiac arrest - Google Patents

Methods for treating a mammal before, during and after cardiac arrest

Info

Publication number
ZA200609895B
ZA200609895B ZA200609895A ZA200609895A ZA200609895B ZA 200609895 B ZA200609895 B ZA 200609895B ZA 200609895 A ZA200609895 A ZA 200609895A ZA 200609895 A ZA200609895 A ZA 200609895A ZA 200609895 B ZA200609895 B ZA 200609895B
Authority
ZA
South Africa
Prior art keywords
treating
methods
during
cardiac arrest
mammal before
Prior art date
Application number
ZA200609895A
Other languages
English (en)
Inventor
Max H Weil
Sun Shije
Tang Wanchun
Delgado-Herrera Leticia
Robert J Padley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA200609895B publication Critical patent/ZA200609895B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39—Heart defibrillators
    • A61N1/3904—External heart defibrillators [EHD]
    • A61N1/39044—External heart defibrillators [EHD] in combination with cardiopulmonary resuscitation [CPR] therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200609895A 2004-05-28 2006-11-27 Methods for treating a mammal before, during and after cardiac arrest ZA200609895B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57576504P 2004-05-28 2004-05-28

Publications (1)

Publication Number Publication Date
ZA200609895B true ZA200609895B (en) 2008-10-29

Family

ID=34971382

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609895A ZA200609895B (en) 2004-05-28 2006-11-27 Methods for treating a mammal before, during and after cardiac arrest

Country Status (11)

Country Link
US (1) US20060293395A1 (xx)
EP (1) EP1758584A1 (xx)
JP (1) JP2008501033A (xx)
CN (1) CN101031302A (xx)
AU (1) AU2005249498B2 (xx)
CA (1) CA2568393A1 (xx)
IL (1) IL179628A0 (xx)
MX (1) MXPA06013825A (xx)
TW (1) TW200616639A (xx)
WO (1) WO2005117884A1 (xx)
ZA (1) ZA200609895B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US7650181B2 (en) * 2005-09-14 2010-01-19 Zoll Medical Corporation Synchronization of repetitive therapeutic interventions
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
TWI556796B (zh) * 2014-01-28 2016-11-11 許淑霞 利用心電訊號估計麻醉深度的方法與裝置
EP4233989A3 (en) 2017-06-07 2023-10-11 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
EP3710076B1 (en) 2017-11-13 2023-12-27 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
EP4085965A1 (en) 2018-02-01 2022-11-09 Shifamed Holdings, LLC Intravascular blood pumps and methods of use and manufacture
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
WO2021062265A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
WO2023091392A1 (en) * 2021-11-16 2023-05-25 Juvatech, Llc Aversive electroshock application for behavior modification in insects

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
US4574810A (en) * 1984-10-05 1986-03-11 Lerman Bruce B Automatic threshold defibrillator
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US7045279B1 (en) * 1998-10-22 2006-05-16 Medtronic, Inc. Isolated perfused heart preparation and method of use
US6256535B1 (en) * 1999-06-29 2001-07-03 Pacesetter, Inc. Method for delivering cardiac therapy and a cardiac therapy device for implementing the same

Also Published As

Publication number Publication date
WO2005117884A1 (en) 2005-12-15
JP2008501033A (ja) 2008-01-17
AU2005249498B2 (en) 2010-06-24
TW200616639A (en) 2006-06-01
CA2568393A1 (en) 2005-12-15
IL179628A0 (en) 2007-07-04
US20060293395A1 (en) 2006-12-28
CN101031302A (zh) 2007-09-05
EP1758584A1 (en) 2007-03-07
MXPA06013825A (es) 2007-03-01
AU2005249498A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
ZA200609895B (en) Methods for treating a mammal before, during and after cardiac arrest
EP1720562A4 (en) METHOD FOR TREATING CARDIAL REMODELING AFTER MYOCARDIAL DAMAGE
EP2280675A4 (en) DEVICE AND METHOD FOR AVOIDING BRAIN DAMAGE IN CARDIAC DISORDER, CPR OR HEAVY SHOCK
GB2465917B (en) Rhythm action game apparatus and method
EP1716895A4 (en) GAME PROGRAM, GAME DEVICE, AND GAME METHOD
GB0513301D0 (en) Program parallelizing apparatus, program parallelizing method, and program parallelizing program
EP1706073A4 (en) DEVICES AND METHODS FOR REPAIRING CARDIAC VALVES
EP1742590A4 (en) DEVICE AND METHOD FOR TISSUE TREATMENT
EP1777663A4 (en) AUTHENTICATION METHOD, DEVICE AND PROGRAM
EP1795243A4 (en) GAME PROGRAM, GAME DEVICE, AND GAME METHOD
IL182459A0 (en) Compounds for nonsense suppression, and methods for their use
EP1758121A4 (en) REPRODUCTION DEVICE, PROGRAM, AND REPRODUCTION METHOD
IL180645A0 (en) Methods for treating hepatitis c
EP1571910A4 (en) CYTOTHERAPEUTIC AGENTS, CYTOTHERAPEUTIC UNITS AND METHODS OF TREATMENT IN WHICH THEY INTERVENE
HK1101620A1 (en) Reproduction device, reproduction method and reproduction program
GB0407293D0 (en) A method for the prediction of the likelihood of successful defibrillation for patients exhibiting ventricular fibrillation
EP1747807A4 (en) GAME PROGRAM, GAME DEVICE, AND GAME METHOD
EP1816967A4 (en) TREATMENT APPARATUS COMPRISING STORED PROCESSING PROTOCOLS AND CORRESPONDING METHOD
EP1814451A4 (en) SYSTEM, METHOD AND DEVICE FOR DETECTING A CARDIAL EVENT
EP1845492A4 (en) DEVICE, AUTHENTICATION METHOD, AND PROGRAM
IL165596A0 (en) System and method for improving heart perfusion inrest and during exercise
EP1755670A4 (en) METHODS FOR TREATING VASCULAR DISEASES
EP1804657A4 (en) METHOD FOR MONITORING EARLY TREATMENT RESPONSE
GB0512318D0 (en) Unauthorized-access prevention method, apparatus and program
EP1795242A4 (en) GAME PROGRAM, GAME DEVICE, AND GAME METHOD